Search

everythinglearnresearchcommunity

for

Search:↓

A dog in Germany was successfully treated for a rare bacterial infection without spreading it to humans.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Optimized emulgels with Levofloxacin effectively treat eye infections with prolonged drug release and safety.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Enzymatic synthesis improved the water solubility of the flavonoid baicalin, which may help treat hair loss conditions.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Researchers identified new compounds in Platycladi Cacumen and found variations in its flavonoid content, which could aid in its quality control.

A rare scalp infection in a 66-year-old woman was successfully treated, leading to full hair regrowth.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

N‐AOHPA is a promising alternative to traditional surfactants for better hair conditioning.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

A new microneedle patch treats hair loss effectively with fewer side effects and less frequent use.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.